# Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder

> **NCT03039842** · PHASE3 · UNKNOWN · sponsor: **National Cheng-Kung University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Bipolar Disorder II

## Interventions

- **DRUG:** Dextromethorphan
- **DRUG:** Memantine
- **DRUG:** dextromethorphan+memantine
- **DRUG:** placebo+valproate

## Key facts

- **NCT ID:** NCT03039842
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03039842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03039842, "Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03039842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*